<![CDATA["Reservedele" fra genmanipulerede grise]]>United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans:
More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.

UKidney, was from a gene-edited pig developed by Revivicor Inc., a subsidiary of United Therapeutics Corporation implanted in Rick Slayman now at home

]]>https://dev.proinvestor.com/forum/topic/447038/reservedele-fra-genmanipulerede-griseRSS for NodeSun, 14 Jun 2026 13:43:33 GMTTue, 04 Feb 2025 18:41:10 GMT60